Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1993-7-15
|
pubmed:abstractText |
Transurethral resection of the prostate (TURP) is the most effective treatment for prostatic obstruction secondary to benign prostatic hyperplasia (BPH). This procedure has a high success rate with a very low mortality rate. Over the last 30 years, however, an unchanged morbidity rate of about 20% following TURP has been reported in the literature. In addition, haemorrhage requiring blood transfusion may occur in 6.5-22% of cases, and 68-92% of sexually active men have retrograde ejaculation following TURP. The side-effects and complications associated with TURP have led to the search for alternative therapies. The TULIP system represents a new treatment modality. TULIP is an acronym for transurethral ultrasound-guided laser-induced prostatectomy. The basic TULIP system consists of an ultrasound imager and a 20-F transurethral probe with an ultrasound transducer and a laser window at the distal end. Under ultrasound guidance laser treatment results in a coagulation necrosis effect in the hyperplastic prostate tissue. Coagulation necrosis is basically a bloodless tissue removal procedure as the tissue subsequently sloughs away in the fine particles during spontaneous micturation within 4-6 weeks after the procedure. Early results obtained in the first 18 patients with symptomatic, obstructive BPH treated by TULIP and with a follow-up of 6 weeks to 6 months demonstrate a significant improvement in both subjective and objective symptoms. The peak flow rate increased by up to 142% on average; the residual volume decreased by up to 75%; and there was a 77% decrease in average symptom scores compared with preoperative scores.(ABSTRACT TRUNCATED AT 250 WORDS)
|
pubmed:language |
ger
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0340-2592
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
32
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
225-31
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:7685555-Aged,
pubmed-meshheading:7685555-Equipment Design,
pubmed-meshheading:7685555-Follow-Up Studies,
pubmed-meshheading:7685555-Humans,
pubmed-meshheading:7685555-Laser Therapy,
pubmed-meshheading:7685555-Male,
pubmed-meshheading:7685555-Middle Aged,
pubmed-meshheading:7685555-Postoperative Complications,
pubmed-meshheading:7685555-Prostatectomy,
pubmed-meshheading:7685555-Prostatic Hyperplasia,
pubmed-meshheading:7685555-Reoperation,
pubmed-meshheading:7685555-Ultrasonography,
pubmed-meshheading:7685555-Urinary Bladder Neck Obstruction,
pubmed-meshheading:7685555-Urodynamics
|
pubmed:year |
1993
|
pubmed:articleTitle |
[TULIP--transurethral ultrasound-controlled laser-induced prostatectomy: an alternative to TURP?].
|
pubmed:affiliation |
Urologische Klinik, Ruhr-Universität Bochum, Marienhospital Herne.
|
pubmed:publicationType |
Journal Article,
English Abstract
|